Insights on the Human Vaccine Global Market to 2025 – Public Immunization Programs Funded by Governments are Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Human Vaccine Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.

The publisher has been monitoring the human vaccine market and it is poised to grow by $18.52 billion during 2021-2025 progressing at a CAGR of 7% during the forecast period.

The report on human vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in investments in vaccines segment, need for novel vaccines for chronic infections, and public immunization programs funded by governments.

The human vaccine market analysis includes RoA segment and geographical landscapes. This study identifies the varied demand for vaccines in high-income and developing countries as one of the prime reasons driving the human vaccine market growth during the next few years. Also, R&D of novel vaccines, and advancement in vaccine delivery system will lead to sizable demand in the market.

Companies Mentioned

• Bavarian Nordic AS
• CSL Ltd.
• Daiichi Sankyo Co. Ltd.
• GlaxoSmithKline Plc
• Inovio Pharmaceuticals Inc.
• Merck & Co. Inc.
• Mitsubishi Tanabe Pharma Corp.
• Pfizer Inc.
• Sanofi SA
• Serum Institute of India Pvt. Ltd.

The report on human vaccine market covers the following areas:

• Human vaccine market sizing
• Human vaccine market forecast
• Human vaccine market industry analysis

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Key Topics Covered:

1. Executive Summary

• Market Overview

2. Market Landscape

• Market ecosystem
• Value chain analysis

3. Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020 – 2025

4. Five Forces Analysis

• Five forces summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

5. Market Segmentation by ROA

• Market segments
• Comparison by ROA
• Intramuscular – Market size and forecast 2020-2025
• Subcutaneous – Market size and forecast 2020-2025
• Oral – Market size and forecast 2020-2025
• Others – Market size and forecast 2020-2025
• Market opportunity by ROA

6. Segmentation by Type

• Segmentation by Type

7. Customer landscape

8. Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2020-2025
• Europe – Market size and forecast 2020-2025
• Asia – Market size and forecast 2020-2025
• ROW – Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

9. Vendor Landscape

• Overview
• Landscape disruption

10. Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Bavarian Nordic AS
• CSL Ltd.
• Daiichi Sankyo Co. Ltd.
• GlaxoSmithKline Plc
• Inovio Pharmaceuticals Inc.
• Merck & Co. Inc.
• Mitsubishi Tanabe Pharma Corp.
• Pfizer Inc.
• Sanofi SA
• Serum Institute of India Pvt. Ltd.

11. Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/rqwcpf

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900